IQ EQ Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

IQ EQ Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,191	Closed	-$540K	–	322
2025 Q4	$540K	Buy	1,191 +339	+40%	+$146K	0.04%	250
2025 Q3	$334K	Buy	852 +307	+56%	+$128K	0.02%	278
2025 Q2	$243K	Buy	+545	New	+$251K	0.02%	284
2021 Q4	–	Sell	-1,376	Closed	-$250K	–	264
2021 Q3	$250K	Hold	1,376	–	–	0.04%	245
2021 Q2	$277K	Hold	1,376	–	–	0.04%	236
2021 Q1	$296K	Hold	1,376	–	–	0.05%	221
2020 Q4	$325K	Hold	1,376	–	–	0.08%	188
2020 Q3	$374K	Hold	1,376	–	–	0.11%	153
2020 Q2	$399K	Buy	+1,376	New	+$373K	0.13%	110
2020 Q1	–	Sell	-1,376	Closed	-$301K	–	156
2019 Q4	$301K	Sell	1,376 -382	-22%	-$77.3K	0.1%	128
2019 Q3	$298K	Hold	1,758	–	–	0.1%	129
2019 Q2	$322K	Buy	+1,758	New	+$307K	0.1%	128

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IQ EQ Fund Management's VRTX Position: Q1 2026 in Review

IQ EQ Fund Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 1,191 shares — an estimated $540K sold.

IQ EQ Fund Management first reported a position in VRTX in Q2 2019 and held it in 12 quarters. The position peaked at $540K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

IQ EQ Fund Management reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
IQ EQ Fund Management sold 1,191 Vertex Pharmaceuticals shares in Q1 2026, an estimated $540K.
IQ EQ Fund Management first reported a position in Vertex Pharmaceuticals in Q2 2019 and held it in 12 quarters.
IQ EQ Fund Management's Vertex Pharmaceuticals position peaked at $540K in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.